title: A critical function for Ser-282 in cardiac Myosin binding protein-C phosphorylation and cardiac function.
abstract: BACKGROUND
  Cardiac myosin-binding protein-C (cMyBP-C) phosphorylation at Ser-273, Ser-282, and Ser-302 regulates myocardial contractility. In vitro and in vivo experiments suggest the nonequivalence of these sites and the potential importance of Ser-282 phosphorylation in modulating the protein's overall phosphorylation and myocardial function.
  
  
  OBJECTIVE
  To determine whether complete cMyBP-C phosphorylation is dependent on Ser-282 phosphorylation and to define its role in myocardial function. We hypothesized that Ser-282 regulates Ser-302 phosphorylation and cardiac function during β-adrenergic stimulation.
  
  
  RESULTS
  Using recombinant human C1-M-C2 peptides in vitro, we determined that protein kinase A can phosphorylate Ser-273, Ser-282, and Ser-302. Protein kinase C can also phosphorylate Ser-273 and Ser-302. In contrast, Ca(2+)-calmodulin-activated kinase II targets Ser-302 but can also target Ser-282 at nonphysiological calcium concentrations. Strikingly, Ser-302 phosphorylation by Ca(2+)-calmodulin-activated kinase II was abolished by ablating the ability of Ser-282 to be phosphorylated via alanine substitution. To determine the functional roles of the sites in vivo, three transgenic lines, which expressed cMyBP-C containing either Ser-273-Ala-282-Ser-302 (cMyBP-C(SAS)), Ala-273-Asp-282-Ala-302 (cMyBP-C(ADA)), or Asp-273-Ala-282-Asp-302 (cMyBP-C(DAD)), were generated. Mutant protein was completely substituted for endogenous cMyBP-C by breeding each mouse line into a cMyBP-C null (t/t) background. Serine-to-alanine substitutions were used to ablate the abilities of the residues to be phosphorylated, whereas serine-to-aspartate substitutions were used to mimic the charged state conferred by phosphorylation. Compared to control nontransgenic mice, as well as transgenic mice expressing wild-type cMyBP-C, the transgenic cMyBP-C(SAS(t/t)), cMyBP-C(ADA(t/t)), and cMyBP-C(DAD(t/t)) mice showed no increases in morbidity and mortality and partially rescued the cMyBP-C((t/t)) phenotype. The loss of cMyBP-C phosphorylation at Ser-282 led to an altered β-adrenergic response. In vivo hemodynamic studies revealed that contractility was unaffected but that cMyBP-C(SAS(t/t)) hearts showed decreased diastolic function at baseline. However, the normal increases in cardiac function (increased contractility/relaxation) as a result of infusion of β-agonist was significantly decreased in all of the mutants, suggesting that competency for phosphorylation at multiple sites in cMyBP-C is a prerequisite for normal β-adrenergic responsiveness.
  
  
  CONCLUSIONS
  Ser-282 has a unique regulatory role in that its phosphorylation is critical for the subsequent phosphorylation of Ser-302. However, each residue plays a role in regulating the contractile response to β-agonist stimulation.
authors: Department of Cell and Molecular Physiology, Stritch School of Medicine, Loyola University Chicago, IL, USA.
authors: Sakthivel
authors: S
authors: Sadayappan
authors: James
authors: J
authors: Gulick
authors: Hanna
authors: H
authors: Osinska
authors: David
authors: D
authors: Barefield
authors: Friederike
authors: F
authors: Cuello
authors: Metin
authors: M
authors: Avkiran
authors: Valerie M
authors: VM
authors: Lasko
authors: John N
authors: JN
authors: Lorenz
authors: Marjorie
authors: M
authors: Maillet
authors: Jody L
authors: JL
authors: Martin
authors: Joan Heller
authors: JH
authors: Brown
authors: Donald M
authors: DM
authors: Bers
authors: Jeffery D
authors: JD
authors: Molkentin
authors: Jeanne
authors: J
authors: James
authors: Jeffrey
authors: J
authors: Robbins
references: J Biol Chem. 1984 Dec 25;259(24):15587-96
references: 6549009
references: Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16918-23
references: 17075052
references: Circulation. 2009 Mar 10;119(9):1253-62
references: 19237661
references: Biophys J. 2001 Aug;81(2):1083-92
references: 11463649
references: Circulation. 2005 Feb 22;111(7):906-12
references: 15699252
references: EMBO J. 1995 May 1;14(9):1952-60
references: 7744002
references: J Clin Invest. 1997 Nov 1;100(9):2189-95
references: 9410895
references: Circ Res. 2002 Mar 22;90(5):594-601
references: 11909824
references: J Mol Cell Cardiol. 2000 Sep;32(9):1595-607
references: 10966823
references: FEBS Lett. 1999 Jun 25;453(3):254-9
references: 10405155
references: J Biol Chem. 1991 Feb 15;266(5):2811-7
references: 1671569
references: J Mol Biol. 1975 Dec 25;99(4):609-17
references: 814246
references: Arch Biochem Biophys. 1998 Oct 15;358(2):313-9
references: 9784245
references: J Biol Chem. 2011 Feb 18;286(7):5300-10
references: 21148481
references: J Mol Cell Cardiol. 2010 May;48(5):866-75
references: 19962384
references: Rev Physiol Biochem Pharmacol. 1999;138:203-34
references: 10396142
references: Am J Physiol Heart Circ Physiol. 2001 Feb;280(2):H756-66
references: 11158975
references: Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H1220-8
references: 12763745
references: Circ Res. 2005 Nov 25;97(11):1156-63
references: 16224063
references: Ann N Y Acad Sci. 2008 Mar;1123:1-9
references: 18375572
references: J Cell Biol. 1993 Nov;123(3):619-26
references: 8227129
references: J Mol Cell Cardiol. 2007 Aug;43(2):223-9
references: 17560599
references: Biochemistry. 1994 Oct 25;33(42):12729-34
references: 7918499
references: Biochem J. 1978 Jun 1;171(3):813-6
references: 352343
references: Am J Physiol. 1994 Aug;267(2 Pt 2):H431-42
references: 7915082
references: Circ Res. 1999 Oct 29;85(9):841-7
references: 10532952
references: J Mol Biol. 2003 Aug 15;331(3):713-24
references: 12899839
references: J Mol Biol. 1978 Oct 5;124(4):571-86
references: 152359
references: J Biol Chem. 2007 Nov 30;282(48):35078-87
references: 17923476
references: J Clin Invest. 1999 Nov;104(9):1235-44
references: 10545522
references: J Mol Cell Cardiol. 2010 Dec;49(6):1003-11
references: 20850451
references: Circulation. 2006 Aug 15;114(7):670-80
references: 16894034
references: J Mol Biol. 1985 Nov 5;186(1):185-95
references: 2934553
references: J Mol Biol. 1973 Mar 15;74(4):653-76
references: 4269687
references: J Biol Chem. 2010 Feb 19;285(8):5674-82
references: 20018870
references: Circulation. 2006 Feb 14;113(6):e85-151
references: 16407573
references: Eur J Biochem. 1996 Jan 15;235(1-2):317-23
references: 8631348
references: Proteomics. 2006 Jul;6(14):4176-86
references: 16791825